CVS Health (NYSE:CVS) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, February 12th. Analysts expect CVS Health to post earnings of $1.68 per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.
Shares of CVS Health stock opened at $71.56 on Monday. The company has a debt-to-equity ratio of 1.32, a quick ratio of 0.61 and a current ratio of 0.92. The firm’s 50-day simple moving average is $72.88 and its 200-day simple moving average is $67.15. CVS Health has a twelve month low of $51.72 and a twelve month high of $77.03. The firm has a market cap of $92.16 billion, a P/E ratio of 21.17, a price-to-earnings-growth ratio of 1.51 and a beta of 0.93.
The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, January 22nd. This represents a $2.00 annualized dividend and a dividend yield of 2.79%. CVS Health’s dividend payout ratio (DPR) is currently 28.25%.
In other CVS Health news, EVP Karen S. Lynch sold 80,143 shares of the business’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $6,010,725.00. Following the transaction, the executive vice president now directly owns 41,831 shares in the company, valued at $3,137,325. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Larry J. Merlo sold 266,476 shares of the business’s stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $74.79, for a total transaction of $19,929,740.04. Following the completion of the transaction, the chief executive officer now owns 703,497 shares in the company, valued at $52,614,540.63. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 404,182 shares of company stock worth $30,121,266. Company insiders own 0.53% of the company’s stock.
CVS Health Company Profile
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
See Also: Golden Cross
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.